Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (781-790 of 13,985) with videos related to

Pageof 1,399
Sort By:
Leukemia|June 25, 2010
Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cellsT R Daniels, I I Neacato, J A Rodríguez, et al.
Leukemia|July 9, 2010
Identification of HLA-A*0201-presented T-cell epitopes derived from the tumor-associated antigen M-phase phosphoprotein II in patients with acute myeloid leukemiaS Siegel, S Wirth, D Kabelitz, et al.
Leukemia|July 9, 2010
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndromeM Carlsten, B C Baumann, M Simonsson, et al.
Leukemia|July 3, 2010
The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alterationO Abdel-Wahab, O Kilpivaara, J Patel, et al.
Leukemia|August 13, 2010
Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myelomaE L Davenport, A Zeisig, L I Aronson, et al.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Leukemia|June 18, 2010
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignanciesJ Adélaïde, V Gelsi-Boyer, J Rocquain, et al.
Leukemia|June 4, 2010
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosisP Guglielmelli, F Biamonte, A Spolverini, et al.
Leukemia|June 4, 2010
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patientsM Marega, R G Piazza, A Pirola, et al.
Leukemia|June 4, 2010
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesisP Burda, P Laslo, T Stopka
Pageof 1,399

Showing results (781-790 of 13,985) with videos related to

Sort By:
Pageof 1,399
Leukemia|June 25, 2010
Disruption of HOX activity leads to cell death that can be enhanced by the interference of iron uptake in malignant B cellsT R Daniels, I I Neacato, J A Rodríguez, et al.
Leukemia|July 9, 2010
Identification of HLA-A*0201-presented T-cell epitopes derived from the tumor-associated antigen M-phase phosphoprotein II in patients with acute myeloid leukemiaS Siegel, S Wirth, D Kabelitz, et al.
Leukemia|July 9, 2010
Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndromeM Carlsten, B C Baumann, M Simonsson, et al.
Leukemia|July 3, 2010
The most commonly reported variant in ASXL1 (c.1934dupG;p.Gly646TrpfsX12) is not a somatic alterationO Abdel-Wahab, O Kilpivaara, J Patel, et al.
Leukemia|August 13, 2010
Targeting heat shock protein 72 enhances Hsp90 inhibitor-induced apoptosis in myelomaE L Davenport, A Zeisig, L I Aronson, et al.
Leukemia|August 13, 2010
The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registryM Michallet, M Sobh, D Milligan, et al.
Leukemia|June 18, 2010
Gain of CBL-interacting protein, a possible alternative to CBL mutations in myeloid malignanciesJ Adélaïde, V Gelsi-Boyer, J Rocquain, et al.
Leukemia|June 4, 2010
Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosisP Guglielmelli, F Biamonte, A Spolverini, et al.
Leukemia|June 4, 2010
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patientsM Marega, R G Piazza, A Pirola, et al.
Leukemia|June 4, 2010
The role of PU.1 and GATA-1 transcription factors during normal and leukemogenic hematopoiesisP Burda, P Laslo, T Stopka
Pageof 1,399